Avectas

Ireland
Maynooth, Leinster, Ireland, W23 WK26

Company profile

Avectas company profile

Avectas is a cell engineering technology company, enabling drug developers to manufacture potent engineered cell therapies at therapeutic volumes, with high efficiency and with minimal cell disruption. Avectas technology delivers advanced molecules such as mRNA, proteins and gene editing tools to a range of cell types including T cells for immuno-oncology applications. Unlike the current industry standard of vector-free delivery methods, cells engineered with Avectas technology require no recovery time, leading to a shorter, simpler, more cost effective process.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2010-01-01, Year

Headquarters

Postal code
W23 WK26
Country code
IE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
4
Total equity funding
$30M
Last funding
Grant / $5.3M / 2021-04-22
Last equity funding
Series C / $20M
Investors
3
Lead investors
3
Founders
2
Articles
23

Founders and investors

Founders

Michael MaguireShirley O'Dea

Lead investors

Disruptive Technologies Innovation FundEISMEASeamus Mulligan

Investors

Disruptive Technologies Innovation FundEISMEASeamus Mulligan